Angiodynamics (ANGO) Assets Average (2011 - 2026)

Angiodynamics' Assets Average history runs 16 years deep, the most recent figure standing at $263.9 million for Q2 2026.

• Quarterly Assets Average fell 6.67% year-over-year to $263.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $263.9 million (down 6.67% YoY) and the FY2026 annual result came in at $273.7 million, down 8.45% from the prior year.
• Assets Average was $263.9 million for Q2 2026 at Angiodynamics, roughly flat from $265.2 million in the prior quarter.
• Across five years, Assets Average topped out at $557.9 million in Q4 2022 and bottomed at $263.9 million in Q2 2026.
• A 5-year average of $404.5 million and a median of $366.7 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average climbed 0.54% — and 2024, when it slumped 41.11%.
• Angiodynamics' Assets Average stood at $557.9 million in 2022, then dropped by 10.96% to $496.8 million in 2023, then slumped by 41.11% to $292.6 million in 2024, then declined by 8.52% to $267.7 million in 2025, then fell by 1.4% to $263.9 million in 2026.
• Business Quant data shows ANGO's Assets Average at $263.9 million in Q2 2026, $265.2 million in Q1 2026, and $267.7 million in Q4 2025.